Clinical trial
Pilot Untargeted Metabolomics for Primary Aldosteronism in Plasma (PUMPAP)
NCT06076473 is registered in ClinicalTrials.gov with Liverpool University Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Untargeted Metabolomics for Primary Aldosteronism in Plasma (PUMPAP)
- Lead sponsor
- Liverpool University Hospitals NHS Foundation Trust
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 19, 2023
- Completion date
- January 19, 2025
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary aldosteronism